JP2001505910A5 - - Google Patents

Download PDF

Info

Publication number
JP2001505910A5
JP2001505910A5 JP1998526699A JP52669998A JP2001505910A5 JP 2001505910 A5 JP2001505910 A5 JP 2001505910A5 JP 1998526699 A JP1998526699 A JP 1998526699A JP 52669998 A JP52669998 A JP 52669998A JP 2001505910 A5 JP2001505910 A5 JP 2001505910A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP1998526699A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001505910A (ja
Filing date
Publication date
Priority claimed from US08/806,584 external-priority patent/US5736151A/en
Application filed filed Critical
Publication of JP2001505910A publication Critical patent/JP2001505910A/ja
Publication of JP2001505910A5 publication Critical patent/JP2001505910A5/ja
Pending legal-status Critical Current

Links

JP52669998A 1996-12-09 1997-12-03 改良医薬組成物 Pending JP2001505910A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/806,584 1996-12-09
US08/806,584 US5736151A (en) 1996-12-09 1996-12-09 Antibiotic oil suspensions
PCT/US1997/021401 WO1998025621A1 (en) 1996-12-09 1997-12-03 Improved pharmaceutical compositions

Publications (2)

Publication Number Publication Date
JP2001505910A JP2001505910A (ja) 2001-05-08
JP2001505910A5 true JP2001505910A5 (https=) 2005-08-11

Family

ID=25194373

Family Applications (1)

Application Number Title Priority Date Filing Date
JP52669998A Pending JP2001505910A (ja) 1996-12-09 1997-12-03 改良医薬組成物

Country Status (21)

Country Link
US (1) US5736151A (https=)
EP (1) EP0941095B1 (https=)
JP (1) JP2001505910A (https=)
KR (1) KR100544248B1 (https=)
CN (1) CN100413506C (https=)
AT (1) ATE264681T1 (https=)
AU (1) AU746666B2 (https=)
BR (1) BR9714967B1 (https=)
CA (1) CA2269682C (https=)
CZ (1) CZ297632B6 (https=)
DE (1) DE69728783T2 (https=)
DK (1) DK0941095T3 (https=)
ES (1) ES2218705T3 (https=)
FI (1) FI991302A0 (https=)
HU (1) HUP0000564A3 (https=)
NO (1) NO325475B1 (https=)
NZ (1) NZ336183A (https=)
PL (1) PL190662B1 (https=)
PT (1) PT941095E (https=)
SK (1) SK72399A3 (https=)
WO (1) WO1998025621A1 (https=)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002022107A2 (en) * 2000-09-12 2002-03-21 Pharmacia & Upjohn Company Pharmaceutical composition having modified carrier
US7829100B2 (en) * 2000-09-12 2010-11-09 Teagarden Dirk L Pharmaceutical composition having modified carrier
KR100423895B1 (ko) * 2001-02-19 2004-03-24 주식회사 엘지생명과학 셉티오퍼 하이드로클로라이드의 현탁제 조성물
US20040022815A1 (en) * 2002-08-05 2004-02-05 Orchid Health Care Novel pharmaceutical composition of ceftiofur
AU2002328168B2 (en) * 2002-08-07 2008-08-21 Merial Ltd. Novel pharmaceutical composition of ceftiofur
KR20040015622A (ko) * 2002-08-13 2004-02-19 대한뉴팜(주) 세프티오푸르나트륨을 활성성분으로 함유하는 현탁주사액조성물
US7659061B2 (en) * 2002-11-19 2010-02-09 Pharmacia & Upjohn Company Pharmaceutical compositions having a modified vehicle
US7842791B2 (en) * 2002-12-19 2010-11-30 Nancy Jean Britten Dispersible pharmaceutical compositions
US20040214753A1 (en) * 2003-03-20 2004-10-28 Britten Nancy Jean Dispersible pharmaceutical composition for treatment of mastitis and otic disorders
PL1608407T3 (pl) * 2003-03-20 2006-12-29 Pharmacia Corp Dyspergowana kompozycja środka przeciw-zapalnego
JP2007500692A (ja) * 2003-07-31 2007-01-18 ファルマシア・アンド・アップジョン・カンパニー・エルエルシー 乳房炎及び耳障害を治療するための分散性医薬組成物
WO2006008640A1 (en) * 2004-07-15 2006-01-26 Pharmacia & Upjohn Company Llc Non-aqueous suspension containing a drug having an unpleasant taste
CZ300590B6 (cs) * 2006-06-20 2009-06-24 Pliva - Lachema A. S. Farmaceutická kompozice pro injekcní podání
CZ300424B6 (cs) * 2006-06-20 2009-05-13 Pliva - Lachema A. S. Farmaceutická kompozice pro perorální podání
US8309138B2 (en) 2007-02-16 2012-11-13 Aska Pharmaceutical Co., Ltd. Pharmaceutical composition comprising microparticle oily suspension
CN101406447B (zh) * 2007-10-12 2010-08-25 河南农业大学 复方头孢噻呋油混悬注射液制备工艺
WO2010040055A2 (en) * 2008-10-03 2010-04-08 Intekrin Therapeutics, Inc. Oral pharmaceutical formulations for antidiabetic compounds
EP2367572B1 (en) * 2008-11-19 2018-08-29 Merial, Inc. Formulations comprising ceftiofur and benzyl alcohol
LT2874624T (lt) 2012-07-17 2019-12-10 Bayer New Zealand Ltd Injekuojamos antibiotikų kompozicijos ir jų panaudojimo būdai
FR3000392B1 (fr) 2012-12-27 2015-03-27 Virbac Nouvelles compositions pharmaceutiques veterinaires et leur procede de preparation
US9956164B2 (en) 2014-04-16 2018-05-01 Veyx-Pharma Gmbh Veterinary pharmaceutical composition and use thereof
EA201791982A1 (ru) 2015-03-09 2020-02-17 Интекрин Терапьютикс, Инк. Способы лечения неалкогольной жировой болезни печени и/или липодистрофии
WO2018071810A1 (en) * 2016-10-13 2018-04-19 RhinoNase, Inc. Antibiotic compositions for nasal irrigation and methods
AU2018249822A1 (en) 2017-04-03 2019-10-31 Coherus Biosciences Inc. PPArgamma agonist for treatment of progressive supranuclear palsy
CN113209015A (zh) * 2020-01-21 2021-08-06 江西邦诚动物药业有限公司 长效盐酸头孢噻呋混悬注射液及其制备工艺

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB914894A (en) * 1960-08-12 1963-01-09 Beecham Res Lab Injectable pharmaceutical media
NL260648A (https=) * 1961-01-31
US3996355A (en) * 1975-01-02 1976-12-07 American Home Products Corporation Permanent suspension pharmaceutical dosage form
FR2479229B1 (fr) * 1980-03-26 1986-01-17 Clin Midy Nouveaux derives des cephalosporines, leur procede de preparation et les medicaments utilisables comme antibiotiques qui contiennent lesdits derives
US4902683A (en) * 1984-10-25 1990-02-20 The Upjohn Company Crystalline cephalosporin hydrohalide salts
DE3650526T2 (de) * 1985-08-12 1996-10-31 Upjohn Co Umwandlung des cephalosporin-hydrohalid-salzes zu einem alkalimetallsalz
AU617377B2 (en) * 1987-11-10 1991-11-28 Pharmacia & Upjohn Company Cephalosporin antibiotics
US5223496A (en) * 1987-11-10 1993-06-29 The Upjohn Company Cephalosporin antibiotics
US4877782A (en) * 1988-02-16 1989-10-31 The Upjohn Company Zinc ceftiofur complexes
CA2060501A1 (en) * 1989-06-13 1990-12-14 Akwete Adjei Anhydrous oil-based liquid suspension for delivering a medicament
US5721359A (en) * 1993-03-12 1998-02-24 Pharmacia & Upjohn Company Crystalline ceftiofur free acid

Similar Documents

Publication Publication Date Title
JP2000516516A5 (https=)
JP2000513396A5 (https=)
JP2000514445A5 (https=)
JP2000514475A5 (https=)
JP2000515550A5 (https=)
JP2000516626A5 (https=)
JP2000514731A5 (https=)
JP2000509281A5 (https=)
JP2001502526A5 (https=)
JP2000516033A5 (https=)
JP2000515546A5 (https=)
JP2000507945A5 (https=)
JP2001502424A5 (https=)
JP2000508006A5 (https=)
JP2001500761A5 (https=)
JP2001503197A5 (https=)
JP2000515570A5 (https=)
JP2000514019A5 (https=)
JP2000508995A5 (https=)
JP2001505597A5 (https=)
JP2001506611A5 (https=)
JP2000509810A5 (https=)
JP2001500130A5 (https=)
JP2000510766A5 (https=)
JP2001502025A5 (https=)